Logo

bacterial infections

Inflammatix Raises $102M in Series D Financing to Continue Development of Immune-Response Tests

The firm said it will use the financing to develop and commercialize its immune response gene-expression diagnostic tests.

Phase Genomics Wins $1.7M NIH Grant for Virus Discovery Platform Development

The platform, based on the firm's Hi-C technology, is designed to assembly viral genomes from metagenomic samples and associate them with their microbial hosts.

CareDx, IDbyDNA Partner to Develop Infectious Disease Dx for Transplant Patients

The test will identify more than 100 pathogens, as well as drug resistance in viruses and bacteria.

GeneCapture Awarded $250K SBIR Grant to Test Rapid Wound Pathogen Platform

GeneCapture's platform would allow medical providers of all skill levels to quickly treat bacterial infections with the appropriate antibiotics in remote environments

BGI Bloodstream Pathogen Nucleic Acid Detection Kit Gets CE Mark

The kit, developed by BGI Patho-Genesis Pharmaceutical Technology, is designed to construct a metagenomic sequencing library directly from clinical samples.

Nov 9, 2020

Metagenomic Sequencing Can Quickly Identify Pathogens in Body Fluids, New Study Finds

Nov 6, 2020

Multiplex PCR Panels for Joint Infections on the Horizon
Premium

Oct 29, 2020

Inflammatix Awarded $7.4M in Additional BARDA Funding for POC System, Acute Infection Test

Oct 8, 2020

Inflammatix Moving Into Coronavirus Test Market With Gene Expression Host Response Platform
Premium

Sep 24, 2020

Antibiotic Resistance Spread in Europe Informed by Bacterial Plasmid Sequencing

Aug 13, 2020

HelixBind Aims to Circumvent Culture With Rapid Technology to Detect Bloodstream Infections
Premium

Jun 10, 2020

HelixBind Receives $3M NIH Grant to Expand Bloodstream Infection Dx Platform

Jun 3, 2020

OpGen Expands Partnership With New York State Department of Health to Detect AMR Infections

May 11, 2020

Day Zero Diagnostics Using CARB-X Award to Commercialize Antibiotic-Resistance Testing Platform
Premium

May 11, 2020

CARB-X Awards Day Zero Diagnostics $6.2M to Develop Rapid Antibiotic Resistance Platform

Apr 21, 2020

Curetis, Karolinska Institute Collaborate to Identify Bacterial Co-Infections in COVID-19 Patients

Mar 17, 2020

Illumina, IDbyDNA Ink Partnership on NGS Technologies for Infectious Disease

Mar 12, 2020

DIAMONDS Project Using New Classification Approach to Develop Rapid Infectious Disease Tests
Premium

Feb 5, 2020

Scope Fluidics Raises 14M Polish Zloty to Commercialize Rapid POC MDx System

Oct 31, 2019

Sherlock Biosciences Aims to Create Dx Tool for 'Where Testing Should be Done, But Isn't'
Premium

Oct 31, 2019

Genomics Links Fecal Transplant Recipient Infections to Drug-Resistant E. Coli in Donor

Jul 10, 2019

Day Zero Diagnostics Wins $224K SBIR Grant to Fund HAI Outbreak Analysis Tool

May 28, 2019

Group A Streptococcus Vaccine Target Candidates Identified From Global Genome Set

Apr 19, 2019

Oxford Nanopore Sequencing Shows Promise for Diagnosing Prosthetic Joint Infections
Premium

Apr 17, 2019

Drug Resistance in Cystic Fibrosis Lung Infections Associated With Pseudomonas Bacteriophages

Breaking News
The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.